| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |